Search Results
Advertisement
Your search for Christine B. Boers-Doets, RN, MSc,Christine B. Boers-Doets, RN, MSc matches 2 pages
Showing 1 - 2Assessment Tools to Measure Impact of Dermatologic and Mucosal Adverse Eventsa
aEditor’s Note: References to these tools are provided for educational purposes only. Terms of use for these tools may vary and some may be subject to copyright restrictions. Patient-Reported Outcomes version of the CTCAE (PRO-CTCAE) Patient Completed mcAEs Specific Symptom Experience...
How to Measure the Impact of Dermatologic and Mucosal Adverse Events on Symptom Burden and Quality of Life
Targeted anticancer therapies like epidermal growth factor receptor (EGFR) inhibitors, multitargeted tyrosine kinase inhibitors (mTKIs), and mammalian target of rapamycin (mTOR) inhibitors frequently result in dermatologic adverse events and mucosal adverse events, or, taken together, mucocutaneous ...
Advertisement
Advertisement
Nov
Today In Oncology21
Advertisement
© 2024 HSP News Service, L.L.C.
